SynthesisInternational journal of clinical oncology2014

Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials.

Wei-Xiang Qi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.